10-K · September 30, 2026
Nova has strengthened its strategic position through a 5.17 Moz Estelle gold resource, a $43.4 million antimony award and substantial exploration and processing investment, but it remains a pre-revenue exploration…
10-Q · Filed November 13, 2026 · Our reading of the company's report
The latest report
The quarter reflects reported EPS of -$0.32 and revenue of $0.0, with no disclosed quantitative outlook or segment, margin, balance-sheet, or cash-flow detail in the provided filing extract. The principal negative…
The quarter reflects reported EPS of -$0.32 and revenue of $0.0, with no disclosed quantitative outlook or segment, margin, balance-sheet, or cash-flow detail in the provided filing extract. The principal negative signal is that disclosure controls remained ineffective as of September 30, 2026 due to a 3-part material weakness. Management reported no material changes to the risk factors from the June 30, 2026 Form 10-K.
Reported EPS was -$0.32 and reported revenue was $0.0 for the quarter, indicating no disclosed revenue generation and a net loss.
Management identified a material weakness involving 3 areas: insufficient accounting and SEC-reporting personnel, inconsistent process application, and weaknesses in the financial close process.
The CEO and CFO concluded that disclosure controls and procedures were not effective as of September 30, 2026.
The company reported no changes in internal control over financial reporting during the 3 months ended September 30, 2026 that materially affected, or were reasonably likely to materially affect, those controls.
Disclosure controls and procedures were not effective as of September 30, 2026 because of the identified material weakness, increasing the risk of reporting errors or delayed filings.
The material weakness includes 3 deficiencies covering staffing, process consistency, and financial-close controls; remediation is not complete and requires controls to operate effectively for a sufficient testing period.
The filing states there were no material changes to the risk factors disclosed in the June 30, 2026 Form 10-K, limiting evidence of any newly reduced risk exposure.
The 10-Q provides no quantitative revenue or EPS outlook and does not disclose a change to prior guidance.
Nova has strengthened its strategic position through a 5.17 Moz Estelle gold resource, a $43.4 million antimony award and substantial exploration and processing investment, but it remains a pre-revenue exploration…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.
The free pages stop at the last full session. Trader shows every trade as it prints.